SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-031650
Filing Date
2017-05-11
Accepted
2017-05-11 19:16:25
Documents
1
Period of Report
2017-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2999
  Complete submission text file 0001209191-17-031650.txt   4373
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ATYR PHARMA, INC. 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO CA 92121
Business Address
Blackburn Stan (Reporting) CIK: 0001640577 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37378 | Film No.: 17835929